The Movement Disorders Program focuses on clinically relevant research that will lead to improved patient care and enhance the quality of life of patients with Parkinson's and other movement disorders.
Recent clinical initiatives
- Investigation of the prevalence and impact on quality of life of pain syndromes in Parkinson's disease.
- Investigation of the role of continuous dopaminergic stimulation in reducing the incidence of the neurobehavioral effects of medications.
Head, Movement Disorders Program - Dr Andrew H Evans
Neurologist - Dr Wes Thevathasan
A project is being established in collaboration with Associate Professor Stephen Gibson of the National Ageing Research Institute and Dr Michael Farrell of the Florey Institute of Neuroscience and Mental Health to examine the impact of pain on quality of life and functioning in patients with Parkinson's disease. In a separate study, the effect of continuous dopaminergic stimulation on other non-motor symptoms in Parkinson's patients will be examined.